Christoph Zurl
- Infectious Diseases top 10%
- Epidemiology
- Pharmacology
- Molecular Biology
- Applied Microbiology and Biotechnology top 10%
- Co-authors
- Robert KrauseMartin HoeniglJuergen PrattesStefan HatzlPhilipp EllerGregor GorkiewiczEduard SchulzThomas Valentin
- Topics
- Antifungal resistance and susceptibility (7 papers)Fungal Infections and Studies (6 papers)SARS-CoV-2 and COVID-19 Research (2 papers)
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
Christoph Zurl
11 papers receiving 206 citations
Peers
Comparison fields: 5 of 55
- Infectious Diseases 179
- Epidemiology 118
- Pharmacology 36
- Molecular Biology 20
- Applied Microbiology and Biotechnology 17
Countries citing papers authored by Christoph Zurl
This map shows the geographic impact of Christoph Zurl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Zurl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Zurl more than expected).
Fields of papers citing papers by Christoph Zurl
This network shows the impact of papers produced by Christoph Zurl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Zurl. The network helps show where Christoph Zurl may publish in the future.
Co-authorship network of co-authors of Christoph Zurl
This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Zurl. A scholar is included among the top collaborators of Christoph Zurl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Zurl. Christoph Zurl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 22 | |
| 4 | 3 | |
| 5 | 4 | |
| 6 | 5 | |
| 7 | 75 | |
| 8 | 12 | |
| 9 | 7 | |
| 10 | 43 | |
| 11 | 17 | |
| 12 | 17 |
About Christoph Zurl
Christoph Zurl is a scholar working on Infectious Diseases, Clinical Biochemistry and Epidemiology, having authored 12 papers that have together received 208 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (7 papers), Fungal Infections and Studies (6 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Infectious Diseases (179 citations), Applied Microbiology and Biotechnology (17 citations) and Epidemiology (118 citations). Christoph Zurl has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Robert Krause, Martin Hoenigl, Juergen Prattes, Stefan Hatzl, Philipp Eller, Gregor Gorkiewicz, Eduard Schulz, Thomas Valentin, Ines Zollner‐Schwetz and Andreas Meinitzer. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Journal of Biotechnology and Medical Mycology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.